What is the specificity of purple striae (stretch marks) for Cushing's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Specificity of Purple Striae for Cushing's Disease

Purple striae (wide purple stretch marks) are highly specific for Cushing's syndrome, though the exact specificity percentage is not quantified in current guidelines—these striae are considered one of the most discriminating clinical features when present. 1, 2

Clinical Significance of Purple Striae

Purple striae represent one of the most specific physical findings for pathologic hypercortisolism, distinguishing it from more common conditions:

  • Wide purple striae are among the most specific clinical features for Cushing's syndrome, alongside proximal muscle weakness, abnormal fat distribution in supraclavicular and temporal fossae, and decreased linear growth with continued weight gain in children 1

  • Purple striae are considered a "distinctive clinical feature" that helps differentiate true Cushing's syndrome from pseudo-Cushing's states and simple obesity 3

  • When hypercortisolism is severe, signs like purple striae make the diagnosis "unmistakable", though not all patients present with every classical feature 2

Important Clinical Context

While purple striae are highly specific when present, several caveats apply:

  • Many signs and symptoms of Cushing's syndrome are common in the general population (hypertension, weight gain), but purple striae stand out as more discriminating 2

  • The clinical presentation varies based on the extent and duration of cortisol excess, so purple striae may not be present in all cases, particularly in mild or early disease 2

  • No single clinical feature has 100% sensitivity, so the absence of purple striae does not exclude Cushing's syndrome—biochemical testing remains essential for diagnosis 4, 5

Practical Application

In clinical practice, the presence of wide purple striae should prompt immediate biochemical screening with late-night salivary cortisol (sensitivity 95%, specificity 100%), 24-hour urinary free cortisol, or dexamethasone suppression testing 5, 6. The combination of purple striae with other specific features (proximal myopathy, supraclavicular fat pads, facial plethora) substantially increases diagnostic certainty and warrants urgent endocrine evaluation 1, 3.

References

Research

Evaluation and treatment of Cushing's syndrome.

The American journal of medicine, 2005

Research

Cushing syndrome: maybe not so uncommon of an endocrine disease.

Journal of the American Board of Family Medicine : JABFM, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation of Cushing Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.